// App-Quantinova.ai

: Stagnation in Quality of Next-Generation Sequencing Assays for the Diagnosis of Hereditary Hematopoietic Malignancies

Researchers

Presenter

  • Gregory W. Roloff

Principal Investigators

  • Reid Shaw

  • Timothy E. O'Connor

  • Michael W. Drazer

Medical Centers

  • Section of Hematology/Oncology, The University of Chicago, Chicago, IL

  • Department of Medicine, Loyola University Medical Center, Maywood, IL

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Oncology (ONC)

  • Blood/haematological Diseases

Disease

  • Li-Fraumeni syndrome

  • Solid malignancies

  • Hematology-oncology disease

  • Fanconi anemia, complementation group A

Biomarkers

  • Breast cancer type 1 susceptibility protein

  • Breast cancer type 2 susceptibility protein

  • CCAAT enhancer binding protein alpha

  • Colony stimulating factor 3 receptor

  • Protein Tyrosine Phosphatase, Non-Receptor Type 11

  • checkpoint kinase 2

  • GATA-binding protein 2

  • E3 ubiquitin-protein ligase CBL

  • Fanconi anaemia, complementation group A

  • ETV6-RUNX1

  • Methyl-CpG binding domain protein 4

  • Signal Recognition Particle 72

  • Tumor protein p53

Drug/Treatment

  • TP53

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved